The PhD in Innovation in Immuno-Mediated and Hematological Disorders at Sapienza University of Rome focuses on translating cutting-edge immunology and hematology research into clinically relevant advances. The programme is delivered through two research-focused curricula and supports international collaboration across Europe and North America.
The PhD program in Innovation in Immuno-Mediated and Hematological Disorders at Sapienza University of Rome is designed to bridge the gap between innovative research in immunology and hematology and its clinical applications. This program emphasizes research excellence and international collaboration, fostering a comprehensive understanding of immuno-mediated disorders and hematological conditions.
The program consists of two specialized curricula that focus on cutting-edge research themes:
Applicants must possess a Master’s degree or an equivalent qualification recognized for admission into PhD programs. Proficiency in English is also required, demonstrated through standardized tests such as TOEFL, PTE Academic, or IELTS.
Graduates of this PhD program will be well-equipped for careers in academia, research institutions, and the pharmaceutical industry. They will possess the skills necessary to contribute to advancements in immunology and hematology, making significant impacts on healthcare and clinical practices.
Shortlist scholarships and plan your application — free guidance from our advisors.